{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:04:24Z","timestamp":1772769864899,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["NSFC-82002184"],"award-info":[{"award-number":["NSFC-82002184"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejso.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T21:00:46Z","timestamp":1612990846000},"page":"2286-2294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of prior cancer history on survival of patients with gastric cancer"],"prefix":"10.1016","volume":"47","author":[{"given":"Li","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guansheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.02.007_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2021.02.007_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejso.2021.02.007_bib3","first-page":"271","article-title":"Cancer treatment and survivorship statistics","volume":"66","author":"Miller","year":"2016","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2021.02.007_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib5","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","article-title":"Second malignant neoplasms: assessment and strategies for risk reduction","volume":"30","author":"Wood","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-11-83","article-title":"The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study","volume":"11","author":"Youlden","year":"2011","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2021.02.007_bib7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","article-title":"Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the surveillance, epidemiology, and end results program","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.ejso.2021.02.007_bib8","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2021.02.007_bib9","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2021.02.007_bib10","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(16)32226-7","article-title":"The challenge of screening for early gastric cancer in China","volume":"388","author":"Zong","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejso.2021.02.007_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2019.01.023","article-title":"Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: implications for clinical trial accrual","volume":"90","author":"Wang","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1740774512456453","article-title":"Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment","volume":"9","author":"Filion","year":"2012","journal-title":"Clin Trials"},{"key":"10.1016\/j.ejso.2021.02.007_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/cer.15.27","article-title":"Should criteria for inclusion in cancer clinical trials be expanded?","volume":"4","author":"Gerber","year":"2015","journal-title":"J\u00a0Comp Effect Res"},{"key":"10.1016\/j.ejso.2021.02.007_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju302","article-title":"Impact of prior cancer on eligibility for lung cancer clinical trials","volume":"106","author":"Gerber","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2021.02.007_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2016.12.024","article-title":"Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma","volume":"144","author":"Pierce","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib16","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.18632\/aging.102984","article-title":"Risk of breast cancer-related death in women with a prior cancer","volume":"12","author":"Ji","year":"2020","journal-title":"Aging"},{"issue":"Suppl.\u00a023","key":"10.1016\/j.ejso.2021.02.007_bib17","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/cncr.29049","article-title":"The surveillance, epidemiology, and end results (SEER) program of the national cancer Institute","volume":"120","author":"Cronin","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.02.007_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.ejso.2021.02.007_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4143\/crt.2016.089","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013","volume":"48","author":"Oh","year":"2016","journal-title":"Canc Res Treat : Off J Kor Canc Assoc"},{"key":"10.1016\/j.ejso.2021.02.007_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","article-title":"Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors","volume":"10","author":"Travis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.31543","article-title":"Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: a pan-cancer analysis of the SEER database","volume":"143","author":"Zhou","year":"2018","journal-title":"Int J Canc"},{"key":"10.1016\/j.ejso.2021.02.007_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4143\/crt.2019.210","article-title":"Impact of prior cancer history on the clinical outcomes in advanced breast cancer: a propensity score-adjusted, population-based study","volume":"52","author":"Lin","year":"2020","journal-title":"Canc. Res. Treat."},{"key":"10.1016\/j.ejso.2021.02.007_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000608","article-title":"Impact of prior cancer history on the overall survival of younger patients with lung cancer","volume":"5","author":"Liu","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejso.2021.02.007_bib24","first-page":"1029","article-title":"Anticipating the \"Silver Tsunami\": prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"vol. 25","author":"Bluethmann","year":"2016"},{"issue":"4","key":"10.1016\/j.ejso.2021.02.007_bib25","article-title":"Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual","volume":"107","author":"A","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2021.02.007_bib26","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2017.73.7916","article-title":"Broadening eligibility criteria to make clinical trials more representative: american society of clinical oncology and friends of cancer research joint research statement","volume":"35","author":"Kim","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib27","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1200\/JCO.2007.15.3726","article-title":"Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials","volume":"26","author":"Lemieux","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.02.007_bib28","series-title":"Cancer clinical trial eligibility criteria: patients with organ dysfunction or prior or concurrent malignancies","author":"TFaD","year":"2019"},{"key":"10.1016\/j.ejso.2021.02.007_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10428190802645061","article-title":"Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy","volume":"50","author":"Pulte","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejso.2021.02.007_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lungcan.2016.05.029","article-title":"Prior cancer does not adversely affect survival in locally advanced lung cancer: a national SEER-medicare analysis","volume":"98","author":"Laccetti","year":"2016","journal-title":"Lung Canc"},{"key":"10.1016\/j.ejso.2021.02.007_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv002","article-title":"Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual","volume":"107","author":"Laccetti","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:39:10Z","timestamp":1760060350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0748798321000901"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.02.007","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prior cancer history on survival of patients with gastric cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}